Zachary Conrad Hartman

24PUBLICATIONS
59CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 07, 2026
Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy.

|May 04, 2026
Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory Properties.

|Dec 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity.

Bin-Jin Hwang, Erika J Crosby, David T Severson

|Apr 02, 2025
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd).

Li-Chung Tsao, John S Wang, Xingru Ma

|Mar 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer.

Julio C Tinoco, Harmony I Saunders, Lauryn Rose Werner

|Nov 26, 2024
Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer.

Robert D Marek, Selena Halabi, Mu-En Wang

Pageof 4

Frequent Collaborators

16 joint publications

Herbert Kim Lyerly

9 joint publications

Erika J Crosby

6 joint publications

Chaitanya R Acharya

4 joint publications

Jason McBane